Elsevier Inc.

SHERPA: Unknown

People

  1. Postow
    Postow
  2. Lesokhin
    Lesokhin
  3. Segal
    Segal
  4. Wong
    Wong
  5. Busam
    Busam
  6. Chaft
    Chaft
  7. D'Angelo
    D'Angelo
  8. Drilon
    Drilon
  9. Motzer
    Motzer
  10. Qin
    Qin

Groups

  1. Department of Medicine (11)
  2. Melanoma Disease Management Team (11)
  3. Melanoma and Immunotherapeutics Service (11)
  4. Solid Tumor Oncology Division (11)
  5. GSK Faculty (6)
  6. Hematologic Malignancies, Division of (4)
  7. Center for Hematologic Malignancies (2)
  8. Gastrointestinal Oncology Service (2)
  9. Hematologic Malignancies Research (2)
  10. Myeloma (2)
Search Within
  1. "Melanoma Disease Management Team"
  2. "European Journal of Cancer"
  3. "Solid Tumor Oncology Division"
Formats
  1. Journal Article (6)
  2. Meeting Abstract (5)
Groups
  1. Department of Medicine (11)
  2. Melanoma Disease Management Team (11)
  3. Melanoma and Immunotherapeutics Service (11)
  4. Solid Tumor Oncology Division (11)
  5. GSK Faculty (6)
  6. Hematologic Malignancies, Division of (4)

More Groups

People
  1. Michael Postow (9)
  2. Jedd Wolchok (6)
  3. Margaret Callahan (3)
  4. Alexander Lesokhin (2)
  5. Jianda Yuan (2)
  6. Matthew Hellmann (2)

More People

Years
  1. 2024 (1)
  2. 2022 (1)
  3. 2017 (2)
  4. 2016 (2)
  5. 2015 (2)
  6. 2013 (3)
Publications
  1. European Journal of Cancer (11)

Results (11)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • The features and management of acquired resistance to PD1-based therapy in metastatic melanoma
    Journal Article

    Hepner, A.; Versluis, J. M.; Wallace, R.; Allayous, C.; Brown, L. J.; Trojaniello, C.; Gerard, C. L.; Jansen, Y. J. L.; Bhave, P.; Neyns, B.; more...
    European Journal of Cancer (2024)

    Fulltext@MSK | Save
  • A randomised phase II trial of a trivalent ganglioside vaccine targeting GM2, GD2 and GD3 combined with immunological adjuvant OPT-821 versus OPT-821 alone in metastatic sarcoma patients rendered disease-free by surgery
    Journal Article

    Rosenbaum, E.; Chugh, R.; Ryan, C. W.; Agulnik, M.; Milhem, M. M.; George, S.; Jones, R. L.; Chmielowski, B.; Van Tine, B. A.; Tawbi, H.; more...
    European Journal of Cancer (2022)

    Fulltext@MSK | Save
  • Health-related quality of life results from the phase III CheckMate 067 study
    Journal Article

    Schadendorf, D.; Larkin, J.; Wolchok, J.; Hodi, F. S.; Chiarion-Sileni, V.; Gonzalez, R.; Rutkowski, P.; Grob, J. J.; Cowey, C. L.; Lao, C.; more...
    European Journal of Cancer (2017)

    Fulltext@MSK | Save
  • Peripheral CD8 effector-memory type 1 T-cells correlate with outcome in ipilimumab-treated stage IV melanoma patients
    Journal Article

    Wistuba-Hamprecht, K.; Martens, A.; Heubach, F.; Romano, E.; Geukes Foppen, M.; Yuan, J.; Postow, M.; Wong, P.; Mallardo, D.; Schilling, B.; more...
    European Journal of Cancer (2017)

    Fulltext@MSK | Save
  • Proportions of blood-borne Vδ1+ and Vδ2+ T-cells are associated with overall survival of melanoma patients treated with ipilimumab
    Journal Article

    Wistuba-Hamprecht, K.; Martens, A.; Haehnel, K.; Geukes Foppen, M.; Yuan, J.; Postow, M. A.; Wong, P.; Romano, E.; Khammari, A.; Dreno, B.; more...
    European Journal of Cancer (2016)

    Fulltext@MSK | Save
  • Characterisation and management of dermatologic adverse events to agents targeting the PD-1 receptor
    Journal Article

    Belum, V. R.; Benhuri, B.; Postow, M. A.; Hellmann, M. D.; Lesokhin, A. M.; Segal, N. H.; Motzer, R. J.; Wu, S.; Busam, K. J.; Wolchok, J. D.; more...
    European Journal of Cancer (2016)

    Fulltext@MSK | Save
  • A phase 1b/2 study of ribociclib (LEE011; CDK4/6 inhibitor) in combination with binimetinib (MEK162; MEK inhibitor) in patients with NRAS-mutant melanoma
    Meeting Abstract

    van Herpen, C.; Postow, M. A.; Carlino, M. S.; Kalkavan, H.; Weise, A.; Amaria, R. N.; De Vos, F.; Carvajal, R. D.; Matano, A.; Bhansali, S.; more...
    European Journal of Cancer (2015)

    Fulltext@MSK | Save
  • Pneumonitis with anti-PD-1/PD-L1 therapy
    Meeting Abstract

    Naidoo, J.; Cunningham, J.; Woo, K. M.; Hellmann, M. D.; Postow, M. A.; Drilon, A. E.; Chaft, J. E.; Lesokhin, A. M.; Segal, N. H.; Callahan, M. K.; more...
    European Journal of Cancer (2015)

    Fulltext@MSK | Save
  • Combined nivolumab (anti-PD-1, BMS-936558, ONO-4538) and ipilimumab in the treatment of advanced melanoma (MEL) patients (pts): Safety and clinical activity
    Meeting Abstract

    Sznol, M.; Callahan, M. K.; Kluger, H.; Postow, M. A.; Burke, M.; Hong, Q.; Selby, M.; Korman, A.; Gupta, A.; Wolchok, J. D.
    European Journal of Cancer (2013)

    Fulltext@MSK | Save
  • Engaging in adaptive tumour response in cancer
    Meeting Abstract

    Postow, M.
    European Journal of Cancer (2013)

    Fulltext@MSK | Save